$SCYX
SCYNEXIS Inc

2022 Q1 Form 10-Q Financial Statement

#000156459022019843 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $687.0K $12.05M
YoY Change -94.3%
Cost Of Revenue $99.00K
YoY Change
Gross Profit $588.0K
YoY Change
Gross Profit Margin 85.59%
Selling, General & Admin $14.59M $6.696M
YoY Change 117.91% 156.26%
% of Gross Profit 2481.46%
Research & Development $5.735M $6.948M
YoY Change -17.46% -29.58%
% of Gross Profit 975.34%
Depreciation & Amortization $155.0K $27.00K
YoY Change 474.07% -3.57%
% of Gross Profit 26.36%
Operating Expenses $20.33M $13.64M
YoY Change 48.97% 9.34%
Operating Profit -$19.74M -$1.594M
YoY Change 1138.27% -87.23%
Interest Expense $9.574M $214.0K
YoY Change 4373.83% 1.9%
% of Operating Profit
Other Income/Expense, Net $9.587M -$1.982M
YoY Change -583.7% -136.19%
Pretax Income -$10.15M -$3.576M
YoY Change 183.86% -48.91%
Income Tax -$4.700M $1.100M
% Of Pretax Income
Net Earnings -$5.451M -$4.676M
YoY Change 16.57% -33.22%
Net Earnings / Revenue -793.45% -38.8%
Basic Earnings Per Share -$0.17 -$0.18
Diluted Earnings Per Share -$0.18 -$0.23
COMMON SHARES
Basic Shares Outstanding 32.05M 25.80M
Diluted Shares Outstanding 33.19M 26.52M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.21M $92.00M
YoY Change 3.49% 166.67%
Cash & Equivalents $95.20M $92.00M
Short-Term Investments
Other Short-Term Assets $4.000K $370.0K
YoY Change -98.92% -59.52%
Inventory $1.149M
Prepaid Expenses
Receivables $1.628M
Other Receivables $0.00
Total Short-Term Assets $101.9M $95.40M
YoY Change 6.82% 159.24%
LONG-TERM ASSETS
Property, Plant & Equipment $2.810M $3.200M
YoY Change -12.19% -8.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.885M $1.100M
YoY Change 435.0% -8.33%
Total Long-Term Assets $9.656M $4.700M
YoY Change 105.45% 0.0%
TOTAL ASSETS
Total Short-Term Assets $101.9M $95.40M
Total Long-Term Assets $9.656M $4.700M
Total Assets $111.6M $100.1M
YoY Change 11.45% 141.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.130M $6.500M
YoY Change 25.08% 25.0%
Accrued Expenses $4.523M $2.134M
YoY Change 111.95% 18.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $12.94M $24.90M
YoY Change -48.02% 250.7%
LONG-TERM LIABILITIES
Long-Term Debt $44.53M $12.20M
YoY Change 265.0% 9.91%
Other Long-Term Liabilities $4.102M $37.00M
YoY Change -88.91% 118.93%
Total Long-Term Liabilities $4.102M $49.20M
YoY Change -91.66% 75.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.94M $24.90M
Total Long-Term Liabilities $4.102M $49.20M
Total Liabilities $72.64M $74.15M
YoY Change -2.04% 111.53%
SHAREHOLDERS EQUITY
Retained Earnings -$364.9M -$331.3M
YoY Change 10.14% 18.99%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.93M $25.92M
YoY Change
Total Liabilities & Shareholders Equity $111.6M $100.1M
YoY Change 11.48% 141.09%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$5.451M -$4.676M
YoY Change 16.57% -33.22%
Depreciation, Depletion And Amortization $155.0K $27.00K
YoY Change 474.07% -3.57%
Cash From Operating Activities -$15.99M -$760.0K
YoY Change 2003.68% -94.59%
INVESTING ACTIVITIES
Capital Expenditures -$9.000K -$200.0K
YoY Change -95.5% -5100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$9.000K -$200.0K
YoY Change -95.5% -97.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.164M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.723M -71.00K
YoY Change -9569.01% -146.71%
NET CHANGE
Cash From Operating Activities -15.99M -760.0K
Cash From Investing Activities -9.000K -200.0K
Cash From Financing Activities 6.723M -71.00K
Net Change In Cash 6.714M -271.0K
YoY Change -2577.49% -98.75%
FREE CASH FLOW
Cash From Operating Activities -$15.99M -$760.0K
Capital Expenditures -$9.000K -$200.0K
Free Cash Flow -$15.98M -$560.0K
YoY Change 2753.39% -96.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
0
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M2D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
174000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2022Q1 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
40000
CY2021Q4 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
0
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13616000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4102000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7921000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18062000
CY2021Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11607000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
33713000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
28745000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3138000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2022Q1 us-gaap Liabilities
Liabilities
72635000
CY2021Q4 us-gaap Liabilities
Liabilities
78579000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12944000
CY2022Q1 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
10817000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2022Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
403825000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
400705000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6948000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14591000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6696000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364930000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359479000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
38927000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29221158
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29221158
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111562000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119837000
CY2022Q1 scyx Cost Of Product Revenues
CostOfProductRevenues
99000
CY2021Q1 scyx Cost Of Product Revenues
CostOfProductRevenues
0
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5735000
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13000
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
980000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9587000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1982000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10151000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3576000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32051228
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25802700
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33189428
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26523920
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5451000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
155000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
922000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
256000
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
980000
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-90000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
52000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
49000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1736000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
383000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-68000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
200000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2164000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022Q1 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
451000
CY2021Q1 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
62000
CY2022Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5000000
CY2021Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
10000
CY2022Q1 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
0
CY2021Q1 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
15000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6723000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9274000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
CY2022Q1 us-gaap Stock Issued1
StockIssued1
0
CY2021Q1 us-gaap Stock Issued1
StockIssued1
7452000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
178000
CY2022Q1 scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
26000
CY2021Q1 scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
CY2022Q1 scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
27000
CY2022Q1 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
71000
CY2021Q1 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
0
CY2022Q1 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
206000
CY2021Q1 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
0
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364900000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5451000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4676000
CY2022Q1 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
CY2021Q1 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-1323000
CY2022Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-584000
CY2021Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6035000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5999000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32051228
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25802700
CY2022Q1 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
CY2021Q1 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
721220
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1138200
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33189428
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26523920
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10879564
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15111905
CY2022Q1 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
753000
CY2021Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
247000
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
206000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
505000
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2956000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2813000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3919000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5486000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5162000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
115000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127000
CY2022Q1 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5604000
CY2021Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5292000
CY2022Q1 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1210000
CY2021Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1498000
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
505000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2012000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1893000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1352000
CY2022Q1 scyx Accrued Rebates Current
AccruedRebatesCurrent
915000
CY2021Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
836000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4523000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
23874000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
11126000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
35000000
CY2022Q1 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1383000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36383000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2670000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
33713000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5332000
CY2022Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date.  The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2000
CY2022Q1 us-gaap Lease Cost
LeaseCost
163000
CY2021Q1 us-gaap Lease Cost
LeaseCost
164000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
174000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
170000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
354000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
715000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
730000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
759000
CY2022Q1 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2030000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3215000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3138000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3215000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2117000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29221158
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29221158
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5451000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
922000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2135000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-18000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
71000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
38927000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4676000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
398000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-15000
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15518842
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14367493
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10000000.0
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1300000
CY2022Q1 scyx Fair Value Of Liabilities
FairValueOfLiabilities
8000000.0
CY2021Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
18100000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1542126
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.89
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
550500
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.59
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
42532
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2050094
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
793216
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2050094
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
922000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
398000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1380000
CY2022Q1 scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
1374000
CY2022Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1162000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1592000

Files In Submission

Name View Source Status
0001564590-22-019843-index-headers.html Edgar Link pending
0001564590-22-019843-index.html Edgar Link pending
0001564590-22-019843.txt Edgar Link pending
0001564590-22-019843-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20220331.htm Edgar Link pending
scyx-10q_20220331_htm.xml Edgar Link completed
scyx-20220331.xsd Edgar Link pending
scyx-20220331_cal.xml Edgar Link unprocessable
scyx-20220331_def.xml Edgar Link unprocessable
scyx-20220331_lab.xml Edgar Link unprocessable
scyx-20220331_pre.xml Edgar Link unprocessable
scyx-ex101_26.htm Edgar Link pending
scyx-ex311_8.htm Edgar Link pending
scyx-ex312_7.htm Edgar Link pending
scyx-ex321_6.htm Edgar Link pending
Show.js Edgar Link pending